Information:
Fel:
ID
23048
Beskrivning
Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT00511095
Länk
https://clinicaltrials.gov/show/NCT00511095
Nyckelord
Versioner (1)
- 2017-06-21 2017-06-21 -
Uppladdad den
21 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis B NCT00511095
Eligibility Hepatitis B NCT00511095
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B NCT00511095
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
willing and able to give written informed consent
boolean
C0021430 (UMLS CUI [1])
ID.2
Item
women of childbearing potential must be willing to consistently use a highly effective method of birth control
boolean
C0009862 (UMLS CUI [1])
ID.3
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.4
Item
any previous hbv infection
boolean
C0019169 (UMLS CUI [1])
ID.5
Item
previous vaccination (1 or more doses) with any hbv vaccine
boolean
C0474232 (UMLS CUI [1])
ID.6
Item
any previous autoimmune diseases
boolean
C0004364 (UMLS CUI [1])
ID.7
Item
are at high risk for recent exposure to hbv, hepatitis c virus (hcv) or human immunodeficiency virus (hiv)
boolean
C0332167 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0220847 (UMLS CUI [1,3])
C0019682 (UMLS CUI [1,4])
C0019163 (UMLS CUI [1,2])
C0220847 (UMLS CUI [1,3])
C0019682 (UMLS CUI [1,4])
ID.8
Item
received any blood products or antibodies within 3 months prior to study entry
boolean
C0456388 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
C0003241 (UMLS CUI [1,2])
ID.9
Item
ever received an injection with dna plasmids or oligonucleotides
boolean
C4086231 (UMLS CUI [1,1])
C0028953 (UMLS CUI [1,2])
C0028953 (UMLS CUI [1,2])
ID.10
Item
received any vaccines within 4 weeks prior to study entry
boolean
C0042210 (UMLS CUI [1])
ID.11
Item
received any other investigational medicinal agent within 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])